One of the most pressing and persistent concerns facing Americans of every political stripe is the unchecked growth in out-of-pocket costs of prescription drugs. Fortunately, a bipartisan consensus is quickly gaining momentum in Congress to restore competition and increase transparency in the prescription drug market, potentially saving seniors and the federal government billions of dollars. The solution centers on a strategy of “delinking” pharmacy benefit managers’, or PBMs’, compensation in Medicare away from price manipulations and margins earned on the price of a drug. Instead, PBMs will be paid only transparent, market-based flat fees for services valued by their clients. By end
Hence then, the article about emerging bipartisan path to lowering prescription drug costs reveals common ground for agreements on spending was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Emerging bipartisan path to lowering prescription drug costs reveals common ground for agreements on spending )